FARON Faron Pharmaceuticals Oy
0.4345EUR+6.11%Mkt Cap: 95.82M $P/E: —1d ago
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidate is Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.27BUSDP/E 30.7
$22.99BUSDP/E 14.5
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap95.82M USD
Enterprise Value75.02M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-29.63M USD
Revenue/Share0.01 EUR
Last Price0.4345 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees36
CountryFI
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.28
PEG—
EV/EBITDA-3.59
EV/Revenue—
P/S—
P/B7.18
EPS (TTM)-0.12
EPS (Forward)-0.13
52W Range
0.38802% of range2.430
52W High2.430 EUR
52W Low0.3880 EUR
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE147.28%
ROA-158.73%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.48M USD
CapEx (TTM)241.30K USD
FCF Margin—
FCF Yield-13.85%
Net Debt-15.28M USD
Net Debt/EBITDA0.73
Balance Sheet
Debt/Equity-1.33
Current Ratio2.40
Quick Ratio2.28
Book Value/Sh0.06 EUR
Cash/Share0.16 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.262 EUR
Upside (mean)+190.6%
Target Range0.7500 EUR – 2.500 EUR
0.7500+190.6% to mean2.500
# Analysts4
Ownership
Shares Out.202.88M
Float136.59M
Insiders16.17%
Institutions21.05%
Technical
SMA 500.4430 (-1.9%)
SMA 2000.7588 (-42.7%)
Beta1.11
S&P 52W Chg16.45%
Avg Vol (30d)804.97K
Avg Vol (10d)624.68K
Technical Indicators
RSI (14)55.2
MACD-0.0055
MACD Signal-0.0086
MACD Hist.+0.0031
BB Upper0.4314 EUR
BB Middle0.4140 EUR
BB Lower0.3967 EUR
BB Width8.38%
ATR (14)0.0182 EUR
Vol Ratio (20d)1.53x